# Maralixibat for Intrahepatic Cholestasis of Pregnancy

> **NCT07389031** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Imperial College London** · enrollment: 28 (estimated)

## Conditions studied

- Intrahepatic Cholestasis of Pregnancy

## Interventions

- **DRUG:** Maralixibat

## Key facts

- **NCT ID:** NCT07389031
- **Lead sponsor:** Imperial College London
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-04-01
- **Primary completion:** 2028-03-31
- **Final completion:** 2028-03-31
- **Target enrollment:** 28 (ESTIMATED)
- **Last updated:** 2026-02-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07389031

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07389031, "Maralixibat for Intrahepatic Cholestasis of Pregnancy". Retrieved via AI Analytics 2026-07-08 from https://api.ai-analytics.org/clinical/NCT07389031. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*